Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

Marios K. Georgakis, Rainer Malik, Dipender Gill, Nora Franceschini, Cathie Sudlow, Martin Dichgans, Sara Lindstrӧm, Lu Wang, Erin N. Smith, William Gordon, Astrid van Hylckama Vlieg, Mariza de Andrade, Jennifer A. Brody, Jack Pattee, Jeffrey Haessler, Ben Brumpton, Daniel I. Chasman, Pierre Suchon, Ming‐Huei Chen, Constance Turman, Marine Germain, Kerri L. Wiggins, James W. MacDonald, Sigrid K. Brækkan, Sebastian M. Armasu,

Article1995

Exercise and the prevention of dyslipidemia and coronary heart disease.

Jean‐Philippe Després, Benoı̂t Lamarche, Claude Bouchard, Angelo Tremblay, Denis Prud’homme

PubMed

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

Abstract

Discussion(0)

Related publications

Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Twilight, the Dawn of a New Era of Aspirin-Free PCI?

Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes

Exercise and the prevention of dyslipidemia and coronary heart disease.